Yin Wu1, Brooke Levis2, Ying Sun3, Ankur Krishnan3, Chen He3, Kira E Riehm4, Danielle B Rice5, Marleine Azar2, Xin Wei Yan3, Dipika Neupane2, Parash Mani Bhandari2, Mahrukh Imran3, Matthew J Chiovitti3, Nazanin Saadat3, Jill T Boruff6, Pim Cuijpers7, Simon Gilbody8, Dean McMillan8, John P A Ioannidis9, Lorie A Kloda10, Scott B Patten11, Ian Shrier12, Roy C Ziegelstein13, Melissa Henry3, Zahinoor Ismail14, Carmen G Loiselle15, Nicholas D Mitchell16, Marcello Tonelli17, Samir Al-Adawi18, Anna Beraldi19, Anna P B M Braeken20, Natalie Büel-Drabe21, Adomas Bunevicius22, Gregory Carter23, Chih-Ken Chen24, Gary Cheung25, Kerrie Clover26, Ronán M Conroy27, Daniel Cukor28, Carlos E da Rocha E Silva29, Eli Dabscheck30, Federico M Daray31, Elles Douven32, Marina G Downing33, Anthony Feinstein34, Panagiotis P Ferentinos35, Felix H Fischer36, Alastair J Flint37, Maiko Fujimori38, Pamela Gallagher39, Milena Gandy40, Simone Goebel41, Luigi Grassi42, Martin Härter43, Josef Jenewein44, Nathalie Jetté45, Miguel Julião46, Jae-Min Kim47, Sung-Wan Kim48, Marie Kjærgaard49, Sebastian Köhler50, Wim L Loosman51, Bernd Löwe52, Rocio Martin-Santos53, Loreto Massardo54, Yutaka Matsuoka55, Anja Mehnert56, Ioannis Michopoulos57, Laurent Misery58, Ricard Navines53, Meaghan L O'Donnell59, Ahmet Öztürk60, Jurate Peceliuniene61, Luis Pintor62, Jennie L Ponsford33, Terence J Quinn63, Silje E Reme64, Katrin Reuter65, Alasdair G Rooney66, Roberto Sánchez-González67, Marcelo L Schwarzbold68, Vesile Senturk Cankorur69, Juwita Shaaban70, Louise Sharpe71, Michael Sharpe72, Sébastien Simard73, Susanne Singer74, Lesley Stafford75, Jon Stone76, Serge Sultan77, Antonio L Teixeira78, Istvan Tiringer79, Alyna Turner80, Jane Walker72, Mark Walterfang81, Liang-Jen Wang82, Jennifer White83, Dana K Wong84, Andrea Benedetti85, Brett D Thombs86. 1. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada; Department of Psychiatry, McGill University, Montréal, QC, Canada. 2. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada. 3. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada. 4. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. 5. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Psychology, McGill University, Montréal, QC, Canada. 6. Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, QC, Canada. 7. EMGO Institute, Vrije Universiteit Amsterdam, the Netherlands. 8. Hull York Medical School and the Department of Health Sciences, University of York, Heslington, York, UK. 9. Department of Clinical, Neuro and Developmental Psychology, Department of Medicine, Department of Health Research and Policy, Department of Biomedical Data Science, Department of Statistics, Stanford University, Stanford, CA, USA. 10. Library, Concordia University, Montréal, QC, Canada. 11. Departments of Community Health Sciences and Psychiatry, University of Calgary, Calgary, AB, Canada; Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, Canada; Cuthbertson & Fischer Chair in Pediatric Mental Health, University of Calgary, Calgary, Canada. 12. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada; Department of Family Medicine, McGill University, Montréal, QC, Canada. 13. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 14. Hotchkiss Brain Institute & O'Brien Institute for Public Health, Calgary, AB, Canada; Department of Psychiatry, Clinical Neuroscience and Community Health Sciences, University of Calgary, Calgary, AB, Canada; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. 15. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Ingram School of Nursing, McGill University, Montréal, QC, Canada; Centre for Nursing Research, Jewish General Hospital, Montréal, QC, Canada; Department of Oncology, Faculty of Medicine, McGill University, Montréal, QC, Canada. 16. Department of Psychiatry, University of Alberta, Edmonton, AB, Canada; Alberta Health Services, Edmonton, AB, Canada. 17. Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. 18. Department of Behavioural Medicine, College of Medicine & Health Sciences, Sultan Qaboos University, Oman, Oman. 19. Psychotherapie und Psychsomatik, kbo Lech-Mangfall-Klinik für Psychatrie, Garmisch-Partenkirchen, Bayern, Germany. 20. Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands; Faculty of Psychology, Open University of the Netherlands, Heerlen, the Netherlands; Department of Health Services Research, CAPHRI School for Public Health and Primary, Maastricht University, Maastricht, the Netherlands. 21. Department of Psychiatry and Psychotherapy, University Hospital Zürich, Zürich, Switzerland. 22. Harvard University, Boston, MA, USA; Lithuanian University of Health Sciences, Kaunas, Lithuania. 23. University of Newcastle, Australia; Calvary Mater Newcastle, Australia. 24. Community Medicine Research Center, Keelung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Keelung, Taiwan; Department of Psychiatry, Keelung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Keelung, Taiwan. 25. University of Auckland, Auckland, New Zealand. 26. Centre for Brain and Mental Health Research, University of Newcastle, NSW, Australia. 27. Royal College of Surgeons in Ireland Division of Population Health Sciences, Dublin, Ireland. 28. Rogosin Institute, NY, New York, USA. 29. Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 30. The Alfred Hospital, Prahran, VIC, Australia; Monash University, Melbourne, Australia. 31. National Scientific and Technical Research Council, Buenos Aires, Argentina; Institute of Pharmacology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina. 32. Alzheimer Center Limburg and School for Mental Health and Neuroscience (MHeNs), Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands. 33. School of Psychological Sciences, Monash University, Melbourne, VIC, Australia; Monash Epworth Rehabilitation Research Centre, Epworth HealthCare, Melbourne, VIC, Australia. 34. University of Toronto, Toronto, ON, Canada; Sunnybrook Health Sciences Centre, Toronto, ON, Canada. 35. 2nd Department of Psychiatry, Attikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece; Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK. 36. Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 37. University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. 38. Section of Psychological Science, Division of Health Care Research, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan. 39. School of Psychology, Dublin City University, Dublin, Ireland. 40. The Department of Psychology, Macquarie University, Sydney, Australia. 41. Department of Clinical Psychology and Psychotherapy, Institute of Psychology, Christian-Albrechts University, Kiel, Germany. 42. Institute of Psychiatry, Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy; Psychiatric Unit, Integrated Department of Mental Health and Addictive Behavior, Health Trust, University Hospital, Ferrara, Italy. 43. Department of Medical Psychology, University of Hamburg, Hamburg, Germany. 44. Clinic Zugersee, Center for Psychiatry and Psychotherapie, Oberwil-Zug, Switzerland; University of Zurich, Zurich, Switzerland. 45. Departments of Neurology and Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, NY, New York, USA. 46. Equipa Comunitária de Suporte em Cuidados Paliativos de Sintra, Portugal. 47. Chonnam National University Medical School, Republic of Korea. 48. Department of Psychiatry, Chonnam National University Medical School, Republic of Korea. 49. Endocrinology Research Group, Medical Clinic, University Hospital of North Norway, Norway; Department of Internal Medicine, Kolding Hospital, Hospital Lillebaelt, Denmark. 50. Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands. 51. Onze Lieve vrouw Gasthuis, Amsterdam, the Netherlands. 52. Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 53. Department of Psychiatry and Psychology, Hospital Clinic, IDIBAPS, CIBERSAM, Barcelona, Spain; Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain. 54. Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia, Universidad San Sebastián. Santiago, Chile. 55. Division of Health Care Research, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan; Lifestyle Medicine, Cooperative Graduate Program, The Jikei University Graduate School of Medicine, Tokyo, Japan. 56. Department of Medical Psychology and Medical Sociology, University of Leipzig, Germany. 57. 2nd Department of Psychiatry, Attikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece. 58. Department of Dermatology, University Hospital of Brest, Brest, France. 59. Phoenix Australia, Carlton, VIC, Australia. 60. Bezmialem Vakif University, Istanbul, Turkey. 61. Clinic of Internal Diseases, Family Medicine and Oncology, Vilnius University Faculty of Medicine, Vilnius, Lithuania. 62. Consultation Liaison Psychiatry Unit, Hospital Clínico de Barcelona, Barcelona, Spain; Instituto de Investigaciones Biomédicas Augusto Pi i Sunyer (IDIBAPS), Barcelona, Spain. 63. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. 64. Department of Psychology, Faculty of Social Sciences, University of Oslo, Oslo, Norway; Department of Pain Management and Research, Oslo University Hospital, Oslo, Norway. 65. Private Practice for Psychotherapy and Psycho-oncology, Freiburg, Germany. 66. Division of Psychiatry, University of Edinburgh, Edinburgh, UK; Robert Fergusson Unit, Royal Edinburgh Hospital, NHS Lothian, Edinburgh, UK. 67. Department of Psychiatry, Institut de Neuropsiquiatria i Addiccions, Centre Emili Mira, Parc de Salut Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Centro de Investigación Biomédica En Red de Salud Mental (CIBERSAM), Barcelona, Spain. 68. Department of Internal Medicine, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil. 69. Ankara University Faculty of Medicine Psychiatry Department, Ankara, Turkey. 70. Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia. 71. School of Psychology, The University of Sydney, Sydney, NSW, Australia. 72. University of Oxford, Oxford, UK. 73. Département des sciences de la santé, Université du Québec à Chicoutimi (UQAC), QC, Canada; Centre intersectoriel en santé durable (CISD), QC, Canada; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), QC, Canada. 74. Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre Mainz, Mainz, Germany. 75. Centre for Women's Mental Health, Royal Women's Hospital, Parkville, Australia; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia. 76. University of Edinburgh, Edinburgh, UK. 77. Université de Montréal, QC, Canada; CHU Sainte-Justine, Montréal, QC, Canada. 78. University of Texas Health Science Center at Houston, Houston, TX, USA; Santa Casa BH Ensino & Pesquisa, Belo Horizonte, Brazil. 79. Institute of Behavioral Sciences, Pécs University, Medical School, Pécs, Hungary. 80. IMPACT Strategic Research Centre and School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia; Faculty of Health and Medicine, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia. 81. Neuropsychiatry Unit, Royal Melbourne Hospital, Melbourne, Australia; Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Australia; Florey Institute of Neuroscience and Mental Health, Melbourne, Australia. 82. Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. 83. Monash University, Melbourne, Australia. 84. School of Psychological Sciences, Monash University, Melbourne, VIC, Australia; School of Psychology & Public Health, La Trobe University, Melbourne, Australia. 85. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montréal, QC, Canada; Department of Medicine, McGill University, Montréal, QC, Canada. Electronic address: andrea.benedetti@mcgill.ca. 86. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada; Department of Psychiatry, McGill University, Montréal, QC, Canada; Department of Psychology, McGill University, Montréal, QC, Canada; Department of Medicine, McGill University, Montréal, QC, Canada; Department of Educational and Counselling Psychology, McGill University, Montréal, QC, Canada. Electronic address: brett.thombs@mcgill.ca.
Abstract
OBJECTIVE: Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). METHODS: Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and Mini International Neuropsychiatric Interview (MINI), controlling for HADS-D scores and participant characteristics with and without an interaction term between interview and HADS-D scores. RESULTS: There were 15,856 participants (1942 [12%] with major depression) from 73 studies, including 15,335 (97%) non-psychiatric medical patients, 164 (1%) partners of medical patients, and 357 (2%) healthy adults. The MINI (27 studies, 7345 participants, 1066 major depression cases) classified participants as having major depression more often than the CIDI (10 studies, 3023 participants, 269 cases) (adjusted odds ratio [aOR] = 1.70 (0.84, 3.43)) and the semi-structured SCID (36 studies, 5488 participants, 607 cases) (aOR = 1.52 (1.01, 2.30)). The odds ratio for major depression classification with the CIDI was less likely to increase as HADS-D scores increased than for the SCID (interaction aOR = 0.92 (0.88, 0.96)). CONCLUSION: Compared to the SCID, the MINI may diagnose more participants as having major depression, and the CIDI may be less responsive to symptom severity.
OBJECTIVE: Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). METHODS: Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and Mini International Neuropsychiatric Interview (MINI), controlling for HADS-D scores and participant characteristics with and without an interaction term between interview and HADS-D scores. RESULTS: There were 15,856 participants (1942 [12%] with major depression) from 73 studies, including 15,335 (97%) non-psychiatric medical patients, 164 (1%) partners of medical patients, and 357 (2%) healthy adults. The MINI (27 studies, 7345 participants, 1066 major depression cases) classified participants as having major depression more often than the CIDI (10 studies, 3023 participants, 269 cases) (adjusted odds ratio [aOR] = 1.70 (0.84, 3.43)) and the semi-structured SCID (36 studies, 5488 participants, 607 cases) (aOR = 1.52 (1.01, 2.30)). The odds ratio for major depression classification with the CIDI was less likely to increase as HADS-D scores increased than for the SCID (interaction aOR = 0.92 (0.88, 0.96)). CONCLUSION: Compared to the SCID, the MINI may diagnose more participants as having major depression, and the CIDI may be less responsive to symptom severity.
Authors: Anne M de Graaff; Pim Cuijpers; Mariska Leeflang; Irene Sferra; Jana R Uppendahl; Ralph de Vries; Marit Sijbrandij Journal: Glob Ment Health (Camb) Date: 2021-11-23
Authors: Luigi Grassi; Rosangela Caruso; Martino Belvederi Murri; Richard Fielding; Wendy Lam; Silvana Sabato; Silvia De Padova; Maria Giulia Nanni; Tatiana Bertelli; Laura Palagini; Luigi Zerbinati Journal: Clin Pract Epidemiol Ment Health Date: 2021-12-31
Authors: Yin Wu; Brooke Levis; John P A Ioannidis; Andrea Benedetti; Brett D Thombs Journal: Psychother Psychosom Date: 2020-08-19 Impact factor: 17.659
Authors: Felix Fischer; Brooke Levis; Carl Falk; Ying Sun; John P A Ioannidis; Pim Cuijpers; Ian Shrier; Andrea Benedetti; Brett D Thombs Journal: Psychol Med Date: 2021-02-22 Impact factor: 10.592
Authors: Brett D Thombs; Brooke Levis; Anita Lyubenova; Dipika Neupane; Zelalem Negeri; Yin Wu; Ying Sun; Chen He; Ankur Krishnan; Simone N Vigod; Parash Mani Bhandari; Mahrukh Imran; Danielle B Rice; Marleine Azar; Matthew J Chiovitti; Nazanin Saadat; Kira E Riehm; Jill T Boruff; Pim Cuijpers; Simon Gilbody; John P A Ioannidis; Lorie A Kloda; Scott B Patten; Ian Shrier; Roy C Ziegelstein; Liane Comeau; Nicholas D Mitchell; Marcello Tonelli; Jacqueline Barnes; Cheryl Tatano Beck; Carola Bindt; Barbara Figueiredo; Nadine Helle; Louise M Howard; Jane Kohlhoff; Zoltán Kozinszky; Angeliki A Leonardou; Sandra Nakić Radoš; Chantal Quispel; Tamsen J Rochat; Alan Stein; Robert C Stewart; Meri Tadinac; S Darius Tandon; Iva Tendais; Annamária Töreki; Thach D Tran; Kylee Trevillion; Katherine Turner; Johann M Vega-Dienstmaier; Andrea Benedetti Journal: Can J Psychiatry Date: 2020-10-26 Impact factor: 4.356
Authors: Anita Lyubenova; Dipika Neupane; Brooke Levis; Yin Wu; Ying Sun; Chen He; Ankur Krishnan; Parash M Bhandari; Zelalem Negeri; Mahrukh Imran; Danielle B Rice; Marleine Azar; Matthew J Chiovitti; Nazanin Saadat; Kira E Riehm; Jill T Boruff; John P A Ioannidis; Pim Cuijpers; Simon Gilbody; Lorie A Kloda; Scott B Patten; Ian Shrier; Roy C Ziegelstein; Liane Comeau; Nicholas D Mitchell; Marcello Tonelli; Simone N Vigod; Franca Aceti; Jacqueline Barnes; Amar D Bavle; Cheryl T Beck; Carola Bindt; Philip M Boyce; Adomas Bunevicius; Linda H Chaudron; Nicolas Favez; Barbara Figueiredo; Lluïsa Garcia-Esteve; Lisa Giardinelli; Nadine Helle; Louise M Howard; Jane Kohlhoff; Laima Kusminskas; Zoltán Kozinszky; Lorenzo Lelli; Angeliki A Leonardou; Valentina Meuti; Sandra N Radoš; Purificación N García; Susan J Pawlby; Chantal Quispel; Emma Robertson-Blackmore; Tamsen J Rochat; Deborah J Sharp; Bonnie W M Siu; Alan Stein; Robert C Stewart; Meri Tadinac; S Darius Tandon; Iva Tendais; Annamária Töreki; Anna Torres-Giménez; Thach D Tran; Kylee Trevillion; Katherine Turner; Johann M Vega-Dienstmaier; Andrea Benedetti; Brett D Thombs Journal: Int J Methods Psychiatr Res Date: 2020-10-22 Impact factor: 4.182